D.E. Shaw & Co’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-49,299
| Closed | -$168K | – | 5808 |
|
|
2022
Q2 | $168K | Buy |
49,299
+15,275
| +45% | +$84.2K | ﹤0.01% | 4604 |
|
|
2022
Q1 | $311K | Buy |
+34,024
| New | +$517K | ﹤0.01% | 4634 |
|
|
2021
Q4 | – | Sell |
-3,670
| Closed | -$120K | – | 5866 |
|
|
2021
Q3 | $120K | Sell |
3,670
-2,225
| -38% | -$81.5K | ﹤0.01% | 4689 |
|
|
2021
Q2 | $246K | Sell |
5,895
-1,611
| -21% | -$82.5K | ﹤0.01% | 4370 |
|
|
2021
Q1 | $491K | Sell |
7,506
-2,724
| -27% | -$190K | ﹤0.01% | 3514 |
|
|
2020
Q4 | $672K | Buy |
10,230
+480
| +5% | +$31.3K | ﹤0.01% | 3248 |
|
|
2020
Q3 | $529K | Sell |
9,750
-2,678
| -22% | -$205K | ﹤0.01% | 3209 |
|
|
2020
Q2 | $1.19M | Sell |
12,428
-1,772
| -12% | -$132K | ﹤0.01% | 2802 |
|
|
2020
Q1 | $728K | Sell |
14,200
-16,828
| -54% | -$1.76M | ﹤0.01% | 2980 |
|
|
2019
Q4 | $2.55M | Sell |
31,028
-622
| -2% | -$43.6K | ﹤0.01% | 2285 |
|
|
2019
Q3 | $2.71M | Sell |
31,650
-3,193
| -9% | -$341K | ﹤0.01% | 2134 |
|
|
2019
Q2 | $4.44M | Buy |
34,843
+975
| +3% | +$140K | 0.01% | 1668 |
|
|
2019
Q1 | $6.11M | Buy |
33,868
+1,712
| +5% | +$248K | 0.01% | 1416 |
|
|
2018
Q4 | $3.57M | Sell |
32,156
-615
| -2% | -$80.1K | ﹤0.01% | 1734 |
|
|
2018
Q3 | $4.42M | Buy |
32,771
+21
| +0.1% | +$2.9K | 0.01% | 1653 |
|
|
2018
Q2 | $4.52M | Sell |
32,750
-132
| -0.4% | -$18.2K | 0.01% | 1617 |
|
|
2018
Q1 | $4.54M | Buy |
32,882
+142
| +0.4% | +$19.3K | 0.01% | 1473 |
|
|
2017
Q4 | $4.03M | Buy |
32,740
+335
| +1% | +$46K | 0.01% | 1640 |
|
|
2017
Q3 | $4.42M | Sell |
32,405
-1,103
| -3% | -$167K | 0.01% | 1468 |
|
|
2017
Q2 | $5.88M | Sell |
33,508
-59
| -0.2% | -$8.39K | 0.01% | 1227 |
|
|
2017
Q1 | $4.03M | Buy |
33,567
+305
| +0.9% | +$31.7K | 0.01% | 1424 |
|
|
2016
Q4 | $3.24M | Buy |
33,262
+892
| +3% | +$81.8K | 0.01% | 1635 |
|
|
2016
Q3 | $3.04M | Buy |
32,370
+190
| +0.6% | +$19K | 0.01% | 1617 |
|
|
2016
Q2 | $3.46M | Sell |
32,180
-181
| -0.6% | -$21.2K | 0.01% | 1524 |
|
|
2016
Q1 | $3.88M | Buy |
32,361
+1,263
| +4% | +$133K | 0.01% | 1435 |
|
|
2015
Q4 | $3.7M | Buy |
31,098
+3,401
| +12% | +$439K | 0.01% | 1652 |
|
|
2015
Q3 | $4.72M | Buy |
27,697
+3,938
| +17% | +$755K | 0.01% | 1436 |
|
|
2015
Q2 | $4.6M | Buy |
23,759
+5,402
| +29% | +$1M | 0.01% | 1533 |
|
|
2015
Q1 | $2.72M | Buy |
18,357
+1,241
| +7% | +$189K | ﹤0.01% | 1797 |
|
|
2014
Q4 | $2.67M | Buy |
17,116
+1,673
| +11% | +$241K | ﹤0.01% | 2038 |
|
|
2014
Q3 | $2.21M | Buy |
15,443
+107
| +0.7% | +$15.5K | ﹤0.01% | 2161 |
|
|
2014
Q2 | $2M | Buy |
15,336
+1,805
| +13% | +$229K | ﹤0.01% | 2302 |
|
|
2014
Q1 | $1.66M | Buy |
13,531
+2,212
| +20% | +$240K | ﹤0.01% | 2569 |
|
|
2013
Q4 | $1.2M | Buy |
11,319
+1,270
| +13% | +$123K | ﹤0.01% | 3007 |
|
|
2013
Q3 | $1.13M | Buy |
10,049
+1,486
| +17% | +$169K | ﹤0.01% | 2921 |
|
|
2013
Q2 | $966K | Buy |
+8,563
| New | +$1.05M | ﹤0.01% | 2745 |
|
Other funds holding SRGA
AWS
CLG
GCP
D.E. Shaw & Co's SRGA Position: Q3 2022 in Review
D.E. Shaw & Co sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2022, closing a stake of 49,299 shares — an estimated $168K sold.
D.E. Shaw & Co first reported a position in SRGA in Q2 2013 and held it in 36 quarters. The position peaked at $6.11M in Q1 2019. 36 funds tracked by Wall St. Rank hold SRGA as of Q3 2022.
- D.E. Shaw & Co reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 49,299 Surgalign Holdings, Inc. Common Stock shares in Q3 2022, an estimated $168K.
- D.E. Shaw & Co first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 36 quarters.
- D.E. Shaw & Co's Surgalign Holdings, Inc. Common Stock position peaked at $6.11M in Q1 2019.
- 36 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2022.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.